Dr Paul Jourdan: "Lots of people love to knock Aim. I'm absolutely not in that camp" episode artwork

EPISODE · Oct 20, 2021 · 38 MIN

Dr Paul Jourdan: "Lots of people love to knock Aim. I'm absolutely not in that camp"

from Investors' Chronicle

Paul Jourdan, CEO of Amati Global Investors, tells Christopher Akers why he thinks the Alternative Investment Market is an asset of national importance and shares his thoughts on overpricing in "the year of IPOs". He explains Amati's approach to ESG and discusses the stocks that have been important for them over the last year.Investors' Chronicle has supported private investors in the UK for over 160 years by highlighting rewarding investment opportunities. Investors' Chronicle is a service by the Financial Times. Hosted on Acast. See acast.com/privacy for more information.

Episode metadata supplied by the publisher feed · Published Oct 20, 2021

Embed this episode

Ready to play

Dr Paul Jourdan: "Lots of people love to knock Aim. I'm absolutely not in that camp"

0:00 38:09

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of Investors' Chronicle?

This episode is 38 minutes long.

When was this Investors' Chronicle episode published?

This episode was published on October 20, 2021.

Can I download this Investors' Chronicle episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!